A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers. - Tinker, Anna V.; Altman, Alon D.; Bernardini, Marcus Q.; Ghatage, Prafull; Gien, Lilian T.; Provencher, Diane; Salvador, Shannon; Doucette, Sarah; Oza, Amit M. (Current Oncology, 2022)